Kenneth Turner
President and CEO, Massachusetts Life Sciences Center
Kenneth Turner is President and CEO of the Massachusetts Life
Sciences Center (MLSC), an economic development and
investment agency dedicated to supporting the…Read more Kenneth Turner is President and CEO of the Massachusetts Life
Sciences Center (MLSC), an economic development and
investment agency dedicated to supporting the growth and
development of the life sciences in Massachusetts. He directs and
oversees the center’s operations, investment strategy, programs,
and partnerships.
Prior to joining the MLSC, Mr. Turner served as Director of
Diversity & Inclusion/Compliance with Massport. He oversaw and
managed the Authority’s multiple diversity programs, including
business and supplier diversity, workforce diversity, and airport
concessions, as well as all compliance initiatives associated with
Massport’s Disadvantaged/Minority/Women Business Enterprise programs.
Previously, Mr. Turner served as Deputy Secretary for Administration & Finance for the
Commonwealth of Massachusetts Department of Veterans’ Services. He has over 20-years of
general management and executive experience in various Fortune 100 media and package goods
companies including having served as Senior Vice President of Emerging Markets at AOL Time
Warner as well as having held various marketing positions at Hallmark Cards and Hasbro Toys.
A retired U.S. Navy Captain and submarine nuclear weapons system officer with 26-years of service,
Mr. Turner holds a B.S. degree in Liberal Arts from Southern University and A&M College, Baton Rouge, LA.
MISSION: The Massachusetts Life Sciences Center is an economic development and investment
agency dedicated to supporting the growth and development of the life sciences in Massachusetts,
home to the most verdant and productive life sciences ecosystem in the world. Through publicprivate funding initiatives, the MLSC supports innovation, research & development,
commercialization, and manufacturing activities in the fields of biopharma, medical device,
diagnostics, and digital health. Since its creation in 2007, the MLSC has strategically deployed over
$700 million in Massachusetts, through a combination of grants, loans, capital infrastructure
investments, tax incentives, and workforce programs. These investments have created thousands of
jobs, and propelled the development of new therapies, devices, and scientific advancements that are improving patient health and well-being in Massachusetts and beyond.
